Strong Chinese demand help Danone Q2 sales beat expectations

Danone reported stronger-than-expected second-quarter sales, with like-for-like growth of 4.1%, surpassing the 3.8% consensus, primarily driven by robust demand for infant milk formula and medical nutrition products in China. Despite weakness in the competitive U.S. coffee creamer market, the French consumer goods group also achieved a first-half 2025 recurring operating income of €1.811 billion, with an improved operating margin of 13.2% from 12.7% a year prior, and reiterated its full-year 2025 growth forecasts.

Analysis

Danone (EPA:DANO) reported a solid second quarter, with like-for-like sales growth of 4.1% exceeding the 3.8% analyst consensus. This outperformance was primarily driven by robust demand for high-value infant milk formula and medical nutrition products in China, which successfully counterbalanced pronounced weakness in the competitive U.S. coffee creamer market. Critically, the company demonstrated significant operational leverage, with its first-half recurring operating margin expanding to 13.2% from 12.7% a year prior, indicating effective cost management or pricing power. Management's confidence is further underscored by the reiteration of its full-year 2025 guidance, which projects like-for-like sales growth between 3% and 5% and, importantly, expects recurring operating income to grow at a faster rate than sales, signaling continued margin improvement.

Key Decisions for Investors

• The combination of a top-line beat, significant operating margin expansion, and reaffirmed full-year guidance provides a strong fundamental basis for a positive outlook on the stock.
• Investors should monitor the performance of the U.S. coffee creamer division and Chinese consumer trends, as these represent the key headwind and tailwind, respectively, for Danone's growth profile.
• Given management's forecast for operating income to outpace sales growth, the results support a thesis centered on operational efficiency and continued margin improvement, which could justify initiating or adding to positions.